EverSource Wealth Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

EverSource Wealth Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.96K	Buy
2025 Q1	$2.38K	Sell
2024 Q4	$4.45K	Buy
2024 Q3	$3.93K	Buy
2024 Q2	$3.56K	Buy
2024 Q1	$1.49K	Sell
2023 Q4	$4.23K	Buy
2023 Q3	$1.22K	Buy